Cytek Biosciences Inc. announced that its advanced flow cytometry systems have been purchased by scientists in over 20 countries across five continents. Cytek claims these “robust global sales” have led to expanded operations to keep up with demand. In response to the demand, the company has opened new offices in Tokyo and Amsterdam to “better engage with and support customers.” Cytek Biosciences Amsterdam Office. Courtesy of Cytek Biosciences. “This latest achievement is strong evidence that labs around the world are embracing our technology and what we stand for,” said Dr. Wenbin Jiang, CEO of Cytek Biosciences. “Our roadmap has us continuing to expand our global footprint and continuing to give scientists the tools and support they need to advance their research.”